Cargando…
Five-month Outcomes for Asthmatics with COVID-19 and Associations with Atopy and Inhaled Corticosteroids Use
Autores principales: | Foster, Katharine, Moore, Donyea, Jauregui, Emilio, Andy-Nweye, Aame, Mahdavinia, Mahboobeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849493/ http://dx.doi.org/10.1016/j.jaci.2020.12.537 |
Ejemplares similares
-
Asthma prolongs intubation in COVID-19
por: Mahdavinia, Mahboobeh, et al.
Publicado: (2020) -
Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019
por: Keswani, Anjeni, et al.
Publicado: (2020) -
Atopy and Inhaled Corticosteroid Use Associate with Fewer IL-17(+) Cells in Asthmatic Airways
por: Fattahi, Fatemeh, et al.
Publicado: (2016) -
A032 LATINOS EXPERIENCE LONGER DURATION OF UNCONTROLLED ASTHMA AFTER COVID INFECTION
por: Foster, K., et al.
Publicado: (2021) -
Inhaled corticosteroid treatment for 6 months was not sufficient to normalize phagocytosis in asthmatic children
por: da Silva-Martins, Carmen Lívia Faria, et al.
Publicado: (2013)